SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-140185
Filing Date
2020-12-29
Accepted
2020-12-29 17:03:23
Documents
6
Period of Report
2020-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-39439_28k.htm 8-K 53067
2 EX-4.1 a20-39439_2ex4d1.htm EX-4.1 59339
3 EX-10.1 a20-39439_2ex10d1.htm EX-10.1 84911
4 EX-99.1 a20-39439_2ex99d1.htm EX-99.1 15793
5 EX-99.2 a20-39439_2ex99d2.htm EX-99.2 14366
6 GRAPHIC g394392moi001.jpg GRAPHIC 2666
  Complete submission text file 0001104659-20-140185.txt   232809
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 201423131
SIC: 2834 Pharmaceutical Preparations